secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2022-10-24T23:59:59+00:00
Accession:  0001493152-22-029450
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition closes IPO, raises $66M in gross proceeds
----------------------------------------------------------------

- IPO of 6,600,000 units at $10.00/unit closed on Oct 18, 2022; gross proceeds $66,000,000.
- Simultaneous private placement of 394,000 units to sponsor at $10.00/unit generated $3,940,000 additional.
- Total of $67,320,000 placed in trust account ($10.20 per unit) for benefit of public shareholders.
- Audited balance sheet shows $453,111 shareholders' deficit; going concern note highlights risk if business combination not completed within 9-month period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315222029450/0001493152-22-029450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315222029450/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer